Ascorbic acid (vitamin C) prevented diphtheria toxin from inhibiting the incorporation of [U-14C]-alanine into trichloroacetic acid precipitable material in HeLa cells. Ascorbic acid did not exhibit an effect on the adenosine diphosphate-ribosylation of amino acyl trans ferase II nor did it separate fragment A from fragment B in "nicked" toxin. A non-specific reducing agent, para-methylaminophenol sulfate, exhibited an effect on HeLa cells very similar to the results of ascorbic acid. Citric acid, a tricarboxylic acid, had no effect on HeLa cells.
Summary
Ascorbic acid (vitamin C) prevented diphtheria toxin from inhibiting the incorporation of [U-14C]-alanine into trichloroacetic acid precipitable material in HeLa cells. Ascorbic acid did not exhibit an effect on the adenosine diphosphate-ribosylation of amino acyl trans ferase II nor did it separate fragment A from fragment B in "nicked" toxin. A non-specific reducing agent, para-methylaminophenol sulfate, exhibited an effect on HeLa cells very similar to the results of ascorbic acid. Citric acid, a tricarboxylic acid, had no effect on HeLa cells.
Widespread attention, both public and scientific, has been focused on ascorbic acid (vitamin C) by the book "Vitamin C and the Common Cold" written by PAULING (1) . Since its publication, many double-blind studies concerning the effects of ascorbic acid on the common cold and other respiratory diseases have been reported (2) (3) (4) (5) . These studies involve a small segment of the population and the effects of ascorbic acid on individuals. Although receiving much attention at this time, ascorbic acid has been the subject of research and controversy since its isolation by SZENT-GYORGYI in 1928 (6) . These studies include the action of ascorbic acid on diseases of viral, fungal, and bacterial etiology (7) (8) (9) (10) . One example is diphtheria, a disease resulting from the powerful exotoxin released from the bacterium Corynebacterium diphtheriae (8, 9) .
During the latter part of the 1930's, JUNGEBLUT (8) concluded that ascorbic acid, when used in controlled dosages, was capable of eliciting a protective effect on diphtheria intoxicated guinea pigs as well as inactivating the toxin in vitro. KLENNER (9) reported human case histories of diphtheria treated with massive doses (46g in 48hr) of ascorbic acid in conjunction with diphtheria antitoxin.
In 1959, STRAUSS and HENDEE (17) reported the diphtheria toxin-dependent inhibition of protein synthesis in HeLa cells. Diphtheria toxin is protein in nature with two fragments that can be separated by the action of trypsin and thiols such as 2-mercaptoethanol. DRAZIN et al. (11) have shown that fragment A must be linked to fragment B which binds to the cell membrane for fragment A to enter the cell and catalyze the ADP-ribosylation of transferase II. Once ADP-ribosylatod, the transferase can not function to translocate the growing polypeptide chain from the amino acyl site to the peptidyl site on the ribosome. Thus, synthesis of proteins is decreased in susceptible cells.
The purpose of this experiment is to ascertain if ascorbic acid could prevent the action of diphtheria toxin on HeLa cells grown in lab culture as it does in the intact animal and could ascorbic acid prevent the in vitro cell-free ADP-ribosyla tion reaction. Since JUNGEBLUT (8) concluded that ascorbic acid could inactivate diphtheria toxin in vitro, we used disc-gel electrophoresis to see if ascorbic acid could reduce the disulfide bond of "nicked" toxin which would prevent its in hibition of protein synthesis. These data should show if ascorbic acid has a specific effect on the diphtheria toxin protein or a more general effect such as the cellular membrane. The effect of ascorbic acid on "nicked" toxin was studied by SDS disc gel electrophoresis. A preparation of "nicked" toxin treated with 2-mercaptoethanol exhibits three bands (Fig.1, gel C) . These three bands migrating from top to bottom represent the three species which can be found in a "nicked" toxin pre paration treated with disulfide reducing reagents. The slowest migrating band represents intact toxin or toxin nicked with trypsin but not reduced by thiols. The middle band is fragment B while the fastest moving band is fragment A. Neither of the two bands representing fragments A and B is seen in gel B (Fig.1) when ascorbic acid replaces 2-mercaptoethanol as the reducing agent. Toxin treated with trypsin, but not reduced, also exhibited only one band on SDS disc gel electrophoresis (Fig.1, gel A) . The assay system is described in MATERIALS AND METHODS. The complete system includes NAD (specific activity 167mCi/mmole), diphtheria toxin and transferase II in Tris-Cl buffer, pH7. 6 .
MATERIALS
CPM values are the average of 3 determinations .
a Indicates radioactive NAD .
NAD plus transferase II in the presence of ascorbic acid were the components of the reaction mixture, the radioactivity found in trichloroacetic acid precipitable material was only slightly above background (Table2). (9) has shown clinical evidence which indicates that ascorbic acid not only can be tolerated in massive doses but also is beneficial to an individual in the diseased state. It follows that a proportional increase in parotid ascorbic acid secretion would follow larger doses of ascorbic acid. This would bathe the pharyngeal tissues with high concentrations of ascorbic acid which would certainly diminish the localized infection of diphtheria. These ex periments suggest a pharmacological effect of ascorbic acid as postulated by PAULING (19) and routinely performed by KLENNER (9) in his medical practice . Currently we are attempting to ascertain if the effect is specific for diphtheria toxin toward HeLa cells or will other bacterial toxins and other cell lines be affected by ascorbic acid.
